Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650754 · ClinicalTrials.gov registry record · Phase 2
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility
A Phase 2 study, sponsored by Center for Human Reproduction.
- Terminated
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00650754 is a Phase 2 study that was terminated before completion, run by Center for Human Reproduction. The registered enrollment target is 35 participants.
The verdict
NCT00650754, a Phase 2 study, was terminated before completion, sponsored by Center for Human Reproduction.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with otherwise unexplained infertility and evidence of premature ovarian aging (POA).
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dehydroepiandrosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00650754
The ClinicalTrials.gov registry entry for NCT00650754 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00650754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00650754 about?
NCT00650754 is a clinical study titled "Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility". The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with otherwise unexplained infertility and evidence of premature ovarian aging (POA).
What is the current status of trial NCT00650754?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2008-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00650754?
The interventions under investigation include: Placebo (OTHER), Dehydroepiandrosterone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00650754?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.